BTK and systemic lupus erythematosus: Collectively, these results indicate that the reduced renal pathology; proteinuria; and splenomegaly in lupus mice following BTK inhibition is associated with significantly lower peripheral and intra-renal T-cell numbers, and myeloid cell activation, although the impact on B-cells and autoantibodies was minimal.